Aneja R - Search Results

1

Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.

Aneja R, Liu M, Yates C, Gao J, Dong X, Zhou B, Vangapandu SN, Zhou J, Joshi HC. Aneja R, et al. Cancer Res. 2008 Mar 1;68(5):1495-503. doi: 10.1158/0008-5472.CAN-07-1874. Cancer Res. 2008. PMID: 18316614

2

Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.

Zhou J, Gupta K, Aggarwal S, Aneja R, Chandra R, Panda D, Joshi HC. Zhou J, et al. Among authors: aneja r. Mol Pharmacol. 2003 Apr;63(4):799-807. doi: 10.1124/mol.63.4.799. Mol Pharmacol. 2003. PMID: 12644580

3

Enhancement of paclitaxel-induced microtubule stabilization, mitotic arrest, and apoptosis by the microtubule-targeting agent EM012.

Zhou J, Liu M, Aneja R, Chandra R, Joshi HC. Zhou J, et al. Among authors: aneja r. Biochem Pharmacol. 2004 Dec 15;68(12):2435-41. doi: 10.1016/j.bcp.2004.08.032. Biochem Pharmacol. 2004. PMID: 15548390

4

EM012, a microtubule-interfering agent, inhibits the progression of multidrug-resistant human ovarian cancer both in cultured cells and in athymic nude mice.

Zhou J, Liu M, Luthra R, Jones J, Aneja R, Chandra R, Tekmal RR, Joshi HC. Zhou J, et al. Among authors: aneja r. Cancer Chemother Pharmacol. 2005 May;55(5):461-5. doi: 10.1007/s00280-004-0903-1. Epub 2005 Feb 3. Cancer Chemother Pharmacol. 2005. PMID: 15690203

5

Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011.

Aneja R, Zhou J, Vangapandu SN, Zhou B, Chandra R, Joshi HC. Aneja R, et al. Blood. 2006 Mar 15;107(6):2486-92. doi: 10.1182/blood-2005-08-3516. Epub 2005 Nov 10. Blood. 2006. PMID: 16282340 Free PMC article.

6

Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase.

Zhou J, Liu M, Aneja R, Chandra R, Lage H, Joshi HC. Zhou J, et al. Among authors: aneja r. Cancer Res. 2006 Jan 1;66(1):445-52. doi: 10.1158/0008-5472.CAN-05-1779. Cancer Res. 2006. PMID: 16397260

7

Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.

Aneja R, Vangapandu SN, Lopus M, Chandra R, Panda D, Joshi HC. Aneja R, et al. Mol Pharmacol. 2006 Jun;69(6):1801-9. doi: 10.1124/mol.105.021899. Epub 2006 Mar 3. Mol Pharmacol. 2006. PMID: 16517755

8

Rational design of the microtubule-targeting anti-breast cancer drug EM015.

Aneja R, Lopus M, Zhou J, Vangapandu SN, Ghaleb A, Yao J, Nettles JH, Zhou B, Gupta M, Panda D, Chandra R, Joshi HC. Aneja R, et al. Cancer Res. 2006 Apr 1;66(7):3782-91. doi: 10.1158/0008-5472.CAN-05-2962. Cancer Res. 2006. PMID: 16585205 Free article.

9

Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells.

Liu M, Aneja R, Liu C, Sun L, Gao J, Wang H, Dong JT, Sarli V, Giannis A, Joshi HC, Zhou J. Liu M, et al. Among authors: aneja r. J Biol Chem. 2006 Jun 30;281(26):18090-7. doi: 10.1074/jbc.M601324200. Epub 2006 Apr 20. J Biol Chem. 2006. PMID: 16627469 Free article.

10

Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.

Aneja R, Vangapandu SN, Lopus M, Viswesarappa VG, Dhiman N, Verma A, Chandra R, Panda D, Joshi HC. Aneja R, et al. Biochem Pharmacol. 2006 Aug 14;72(4):415-26. doi: 10.1016/j.bcp.2006.05.004. Epub 2006 May 10. Biochem Pharmacol. 2006. PMID: 16780803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters